GB0419235D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0419235D0
GB0419235D0 GB0419235A GB0419235A GB0419235D0 GB 0419235 D0 GB0419235 D0 GB 0419235D0 GB 0419235 A GB0419235 A GB 0419235A GB 0419235 A GB0419235 A GB 0419235A GB 0419235 D0 GB0419235 D0 GB 0419235D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0419235A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GB0419235A priority Critical patent/GB0419235D0/en
Publication of GB0419235D0 publication Critical patent/GB0419235D0/en
Priority to RU2007106037/04A priority patent/RU2408587C2/ru
Priority to EP10194616A priority patent/EP2301933A1/en
Priority to PT5773278T priority patent/PT1809624E/pt
Priority to EP05773278.6A priority patent/EP1809624B1/en
Priority to DK05773278.6T priority patent/DK1809624T3/da
Priority to RS20140015A priority patent/RS53145B/en
Priority to ES05773278.6T priority patent/ES2442678T3/es
Priority to NZ553335A priority patent/NZ553335A/en
Priority to MEP-2014-3A priority patent/ME01620B/me
Priority to US11/574,340 priority patent/US7838675B2/en
Priority to MX2007002240A priority patent/MX2007002240A/es
Priority to PCT/GB2005/003257 priority patent/WO2006024823A1/en
Priority to CN201210247005.5A priority patent/CN102796081B/zh
Priority to EP10194614A priority patent/EP2311827A1/en
Priority to CA2578441A priority patent/CA2578441C/en
Priority to AU2005279045A priority patent/AU2005279045B2/en
Priority to KR1020077004736A priority patent/KR101280095B1/ko
Priority to SI200531819T priority patent/SI1809624T1/sl
Priority to PL05773278T priority patent/PL1809624T3/pl
Priority to BRPI0514735A priority patent/BRPI0514735B8/pt
Priority to CN2005800372450A priority patent/CN101048401B/zh
Priority to JP2007528961A priority patent/JP4795352B2/ja
Priority to UAA200701569A priority patent/UA92463C2/ru
Priority to MYPI20054004A priority patent/MY148125A/en
Priority to UY29085A priority patent/UY29085A1/es
Priority to ARP050103584A priority patent/AR050617A1/es
Priority to TW094129379A priority patent/TWI369983B/zh
Priority to IL181241A priority patent/IL181241A0/en
Priority to ZA200701454A priority patent/ZA200701454B/xx
Priority to NO20071594A priority patent/NO338749B1/no
Priority to HK07112207.7A priority patent/HK1103742A1/xx
Priority to US12/947,916 priority patent/US8269002B2/en
Priority to JP2011013745A priority patent/JP5364735B2/ja
Priority to US13/336,269 priority patent/US8410123B2/en
Priority to US13/620,075 priority patent/US20130012490A1/en
Priority to US13/833,363 priority patent/US8722883B2/en
Priority to JP2013120663A priority patent/JP5730350B2/ja
Priority to HRP20140023TT priority patent/HRP20140023T1/hr
Priority to CY20141100034T priority patent/CY1114803T1/el
Priority to ARP160102336A priority patent/AR105557A2/es
Ceased legal-status Critical Current

Links

GB0419235A 2004-08-24 2004-08-28 Compounds Ceased GB0419235D0 (en)

Priority Applications (41)

Application Number Priority Date Filing Date Title
GB0419235A GB0419235D0 (en) 2004-08-28 2004-08-28 Compounds
RS20140015A RS53145B (en) 2004-08-28 2005-08-23 PIRIMIDINE SULFONAMIDE DERIVATIVES AS CHEMOKIN RECEPTOR MODULATORS
BRPI0514735A BRPI0514735B8 (pt) 2004-08-28 2005-08-23 derivados de pirimidino sulfonamida como moduladores do receptor de quimiocina.
JP2007528961A JP4795352B2 (ja) 2004-08-28 2005-08-23 ケモカイン受容体モジュレーターとしてのピリミジンスルホンアミド誘導体
PT5773278T PT1809624E (pt) 2004-08-28 2005-08-23 Derivados de pirimidina sulfonamida como moduladores do recetor de quimiocina
CN2005800372450A CN101048401B (zh) 2004-08-28 2005-08-23 作为趋化因子受体调节剂的嘧啶磺酰胺衍生物
DK05773278.6T DK1809624T3 (da) 2004-08-28 2005-08-23 Pyrimidinsulfonamidderivater som kemokinreceptor-modulatorer
UAA200701569A UA92463C2 (ru) 2004-08-28 2005-08-23 Производные пиримидинсульфонамида как модуляторы рецепторов хемокина
ES05773278.6T ES2442678T3 (es) 2004-08-28 2005-08-23 Derivados de pirimidín sulfonamidas como moduladores del receptor de quimioquina
EP10194616A EP2301933A1 (en) 2004-08-28 2005-08-23 Thiopyrimidine derivative, useful as an intermediate for chemokine receptor modulators
MEP-2014-3A ME01620B (me) 2004-08-28 2005-08-23 Pirimidin sulfonamidni derivati kao modulatori hemokinskih receptora
US11/574,340 US7838675B2 (en) 2004-08-28 2005-08-23 Pyrimidine sulphonamide derivatives as chemokine receptor modulators
MX2007002240A MX2007002240A (es) 2004-08-28 2005-08-23 Derivados de pirimidinosulfonamida como moduladores del receptor quimiocina.
PCT/GB2005/003257 WO2006024823A1 (en) 2004-08-28 2005-08-23 Pyrimidine sulphonamide derivatives as chemokine receptor modulators
CN201210247005.5A CN102796081B (zh) 2004-08-28 2005-08-23 作为趋化因子受体调节剂的嘧啶磺酰胺衍生物
EP10194614A EP2311827A1 (en) 2004-08-28 2005-08-23 Thiopyrimidine derivative, useful as an intermediate for chemokine receptor modulators.
CA2578441A CA2578441C (en) 2004-08-28 2005-08-23 Pyrimidine sulphonamide derivatives as chemokine receptor modulators
AU2005279045A AU2005279045B2 (en) 2004-08-28 2005-08-23 Pyrimidine sulphonamide derivatives as chemokine receptor modulators
KR1020077004736A KR101280095B1 (ko) 2004-08-28 2005-08-23 케모킨 수용체 조절제로서의 피리미딘 술폰아미드 유도체
SI200531819T SI1809624T1 (sl) 2004-08-28 2005-08-23 Derivati pirimidinsulfonamida kot modulatorji receptorja kemokina
PL05773278T PL1809624T3 (pl) 2004-08-28 2005-08-23 Pochodne pirymidynosulfonoamidu jako modulatory receptora chemokinowego
RU2007106037/04A RU2408587C2 (ru) 2004-08-24 2005-08-23 Производные пиримидинсульфонамида в качестве модуляторов рецепторов хемокинов
EP05773278.6A EP1809624B1 (en) 2004-08-28 2005-08-23 Pyrimidine sulphonamide derivatives as chemokine receptor modulators
NZ553335A NZ553335A (en) 2004-08-28 2005-08-23 Pyrimidine sulphonamide (sulfonamide) derivatives as chemokine receptor modulators
MYPI20054004A MY148125A (en) 2004-08-28 2005-08-25 Compounds
ARP050103584A AR050617A1 (es) 2004-08-28 2005-08-26 Derivados de pirimidin sulfonamidas como moduladores de receptores de quimioquinas
UY29085A UY29085A1 (es) 2004-08-28 2005-08-26 Derivados de pirimidina 4-sulfonamido sustituidos, compuestos intermedios para su preparación, procedimientos de preparación, composiciones medicinales conteniéndolos y aplicaci0nes
TW094129379A TWI369983B (en) 2004-08-28 2005-08-26 Compounds
IL181241A IL181241A0 (en) 2004-08-28 2007-02-08 Pyrimidine sulphonamide derivatives as chemokine receptor modulators
ZA200701454A ZA200701454B (en) 2004-08-28 2007-02-19 Pyrimidine sulphonamide derivatives as chemokine receptor modulators
NO20071594A NO338749B1 (no) 2004-08-28 2007-03-27 Pyrimidinsulfonamidderivater som kjemokinreseptormodulatorer
HK07112207.7A HK1103742A1 (en) 2004-08-28 2007-11-09 Pyrimidine sulphonamide derivatives as chemokine receptor modulators
US12/947,916 US8269002B2 (en) 2004-08-28 2010-11-17 Pyrimidine sulphonamide derivatives as chemokine receptor modulators
JP2011013745A JP5364735B2 (ja) 2004-08-28 2011-01-26 ケモカイン受容体モジュレーターとしてのピリミジンスルホンアミド誘導体
US13/336,269 US8410123B2 (en) 2004-08-28 2011-12-23 Pyrimidine sulphonamide derivatives as chemokine receptor modulators
US13/620,075 US20130012490A1 (en) 2004-08-28 2012-09-14 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators
US13/833,363 US8722883B2 (en) 2004-08-28 2013-03-15 Pyrimidine sulphonamide derivatives as chemokine receptor modulators
JP2013120663A JP5730350B2 (ja) 2004-08-28 2013-06-07 ケモカイン受容体モジュレーターとしてのピリミジンスルホンアミド誘導体
HRP20140023TT HRP20140023T1 (hr) 2004-08-28 2014-01-08 Derivati pirimidin sulfonamida kao modulatori kemokinskih receptora
CY20141100034T CY1114803T1 (el) 2004-08-28 2014-01-15 Παραγωγα πυριμιδινο σουλφοναμιδιου ως ρυθμιστες υποδοχεων χημειοκινης
ARP160102336A AR105557A2 (es) 2004-08-28 2016-08-01 Derivados de pirimidin sulfonamidas

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0419235A GB0419235D0 (en) 2004-08-28 2004-08-28 Compounds

Publications (1)

Publication Number Publication Date
GB0419235D0 true GB0419235D0 (en) 2004-09-29

Family

ID=33104784

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0419235A Ceased GB0419235D0 (en) 2004-08-24 2004-08-28 Compounds

Country Status (5)

Country Link
CN (1) CN101048401B (ru)
AR (1) AR105557A2 (ru)
GB (1) GB0419235D0 (ru)
UA (1) UA92463C2 (ru)
ZA (1) ZA200701454B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101445813B (zh) * 2007-12-21 2013-03-27 清华大学 一种生产3-羟基丙酸的方法
CA2730477A1 (en) * 2008-07-16 2010-01-21 Astrazeneca Ab Pyrimidyl sulfonaminde derivative and its use for the treatment of chemokine mediated diseases
MY180039A (en) * 2011-07-12 2020-11-20 Astrazeneca Ab N- (6- ( (2r,3s) -3,4-dihydroxybutan-2-yloxy) -2- (4 - fluorobenzylthio) pyrimidin- 4 - yl) -3- methylazetidine- 1 - sulfonamide as chemokine receptor modulator
JP6096808B2 (ja) * 2012-02-07 2017-03-15 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 新規なアゼチジン誘導体
CN112457259B (zh) * 2020-12-08 2024-02-20 重庆康乐制药有限公司 一种磺胺多辛的制备方法

Also Published As

Publication number Publication date
ZA200701454B (en) 2008-07-30
CN101048401A (zh) 2007-10-03
UA92463C2 (ru) 2010-11-10
AR105557A2 (es) 2017-10-18
CN101048401B (zh) 2012-09-12

Similar Documents

Publication Publication Date Title
GB0405933D0 (en) Compounds
EP1737831A4 (en) NEUROLOGICALLY ACTIVE COMPOUNDS
GB0405937D0 (en) Compounds
EP1755617A4 (en) PERFLUORCARBON-SOLUBLE COMPOUNDS
GB0405193D0 (en) Compounds
GB0405272D0 (en) Compounds
GB0405267D0 (en) Compounds
GB0405101D0 (en) Compounds
GB0401269D0 (en) Compounds
GB0408772D0 (en) Compounds
GB0405280D0 (en) Compounds
GB0405893D0 (en) Compounds
GB0403593D0 (en) Compounds
GB0403595D0 (en) Compounds
GB0406916D0 (en) Compounds
GB0403267D0 (en) Compounds
GB0405263D0 (en) Compounds
GB0403993D0 (en) Compounds
GB0403998D0 (en) Compounds
GB0404081D0 (en) Compounds
GB0404083D0 (en) Compounds
GB0404084D0 (en) Compounds
GB0404104D0 (en) Compounds
GB0404215D0 (en) Compounds
GB0405099D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)